Assessment of neurotoxicity and “neuroprotection”
Coronal brain slices allow the study of neurotoxicity and “neuroprotection” under conditions where the differentiation-state and interrelationships of the neurones and glial cells are closer to those occurring in the intact tissue than is the case for co-cultured cell systems. The involvement of glial cells in the excitotoxicity of kainate and the potentiation of this toxicity by inhibition of glutamine synthase can be demonstrated. Longer-term toxicity of kainate may also be compounded by depletion of glutathione levels resulting from inhibition of γ-glutamyleysteine synthase. The involvement of nitric oxide formation in the toxicity of N-methyl-D-aspartate can also be shown. The neurotoxicity of 1-methyl-4-phenylpyridinium can be readily demonstrated in coronal slice preparations. Taurine affords protection against this neurotoxicity. The possible mechanisms of these effects are considered in terms of the cyclic interrelationships between the different events which can lead to cell death.
KeywordsNitric Oxide Glial Cell Glutamine Synthetase Kainic Acid Cerebellar Slice
Unable to display preview. Download preview PDF.
- Bianchi L, Sharp T, Bolam JP, Delia Corte, L (1994) The effect of kainic acid on the release of GABA in rat neostriatum and substantia nigra. Neuro Report 5: 1233–1236Google Scholar
- Cohen G, Werner P (1994) Free radicals, oxidative stress and neurodegeneration. In: Calne DB (ed) Neurodegenerative disease. Saunders, Philadelphia, pp 139-162Google Scholar
- Cooper AJL, Vergara F, Duffy TE (1983) Cerebral glutamine synthetase. In: Hertz L, Kvamme E, McGeer EG, Schousboe A (eds) Glutamate, glutamine and GABA in the central nervous system. Alan Liss, New York, pp 77–93Google Scholar
- Drejer J, Larsson OM, Schousboe A (1982) Characterisation of L-glutamate and L-glutamine uptake into, and release from, astrocytes and neurones cultured from different brain regions. Exper Brain Res 47: 259–269Google Scholar
- Hasegawa E, Takeshiga K, Oishi T, Murai Y, Minikami S (1990) l-Methyl-4-phenyl-pyridinium (MPP+) induces NADH dependent superoxide formation and enhances NADH-dependant lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170: 1049–1055PubMedCrossRefGoogle Scholar
- Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC (1985) Dopaminergic toxicity of rotenone and the l-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implications for the mechanism of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci Lett 62: 389–394PubMedCrossRefGoogle Scholar
- Huxtable RJ (1992) Physiological actions of taurine. Phys Rev 72: 101–159Google Scholar
- McBean GJ, Horner EB, Couée I, Phillips JP, O’Brien M, Lee TC, Tipton KF (1990) Enzymes and glial cells in brain damage and neurodegenerative diseases. In: Dostert P, Riederer P, Strolin Benedetti M, Roncucci R (eds) Early markers in Parkinson’s and Alzheimer’s disease (New vistas in drug research 1). Springer, Wien New York, pp 209–220CrossRefGoogle Scholar
- O’Byrne MB, Tipton KF, McBean GJ (1996) Neurotoxicity of MPP+ as studied in a tissue slice system. Biochem Soc Trans 24: 62SGoogle Scholar
- Olney JW, Ho OL, Rhee V (1971) Cytotoxic effects of acidic and sulphur-containing amino acids on the infant mouse central nervous system. Exper Brain Res 14: 61–76Google Scholar
- Youdim MBH, Riederer P (1993) The role of iron in senescence of dopaminergic neurons in Parkinson’s disease. J Neural Transm [Suppl] 40: 57–67Google Scholar